Form 8-K - Current report:
SEC Accession No. 0001213900-21-037619
Filing Date
2021-07-20
Accepted
2021-07-20 08:31:44
Documents
2
Period of Report
2021-07-20
Items
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 CURRENT REPORT ea144482-8k_180life.htm 8-K 21439
2 PRESS RELEASE ea144482ex99-1_180life.htm EX-99.1 12067
  Complete submission text file 0001213900-21-037619.txt   34678
Mailing Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025
Business Address 830 MENLO AVENUE, SUITE 100 MENLO PARK CA 94025 650-507-0669
180 Life Sciences Corp. (Filer) CIK: 0001690080 (see all company filings)

EIN.: 813832378 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-38105 | Film No.: 211099536
SIC: 2834 Pharmaceutical Preparations